Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy

Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogenei...

Full description

Bibliographic Details
Main Authors: Alexander W Kay, Catherine A Blish
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00289/full
_version_ 1819072462263943168
author Alexander W Kay
Catherine A Blish
author_facet Alexander W Kay
Catherine A Blish
author_sort Alexander W Kay
collection DOAJ
description Pregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogeneic fetus may alter the immunogenicity of influenza vaccines. A large number of studies have evaluated the safety of the influenza vaccine. Here, we will review available studies on the immunogenicity and efficacy of the influenza vaccine during pregnancy, focusing on both humoral and cellular immunity.
first_indexed 2024-12-21T17:38:06Z
format Article
id doaj.art-2c3f4b18443f49e1a494002f4c8cb4b1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-21T17:38:06Z
publishDate 2015-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-2c3f4b18443f49e1a494002f4c8cb4b12022-12-21T18:55:43ZengFrontiers Media S.A.Frontiers in Immunology1664-32242015-06-01610.3389/fimmu.2015.00289145632Immunogenicity and Clinical Efficacy of Influenza Vaccination In PregnancyAlexander W Kay0Catherine A Blish1Stanford University School of MedicineStanford University School of MedicinePregnant women are at high risk from influenza due to disproportionate morbidity, mortality, and adverse pregnancy outcomes following infection. As such, they are classified as a high priority group for vaccination. However, changes in the maternal immune system required to accommodate the allogeneic fetus may alter the immunogenicity of influenza vaccines. A large number of studies have evaluated the safety of the influenza vaccine. Here, we will review available studies on the immunogenicity and efficacy of the influenza vaccine during pregnancy, focusing on both humoral and cellular immunity.http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00289/fullPregnancyantibodyinfluenzaImmunogenicityInactivated influenza vaccine
spellingShingle Alexander W Kay
Catherine A Blish
Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
Frontiers in Immunology
Pregnancy
antibody
influenza
Immunogenicity
Inactivated influenza vaccine
title Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
title_full Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
title_fullStr Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
title_full_unstemmed Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
title_short Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
title_sort immunogenicity and clinical efficacy of influenza vaccination in pregnancy
topic Pregnancy
antibody
influenza
Immunogenicity
Inactivated influenza vaccine
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00289/full
work_keys_str_mv AT alexanderwkay immunogenicityandclinicalefficacyofinfluenzavaccinationinpregnancy
AT catherineablish immunogenicityandclinicalefficacyofinfluenzavaccinationinpregnancy